2026 International Congress

October 4-8, 2026. Seoul, Korea.

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Congenital Portosystemic Shunting: A Wilson’s Disease Mimic

L. Lei, K. Mhapankar, E. Tsochatzis, G. Gillett, S. Shribman, P. Korlipara (London, United Kingdom)
Considering Oral Health to Optimise the Potential for Current and Future Treatments in Parkinson’s Disease

J. Price, H. Martin (Powys, United Kingdom)
Consistent Motor Benefit of Safinamide across Clinically Relevant Subgroups in Japanese Patients with Parkinson’s Disease: A 24-Week Real-World Study

Y. Tsuboi, Y. Kogo, T. Ishida, K. Koizumi, M. Ishii (Tokyo, Japan)
Continued Evaluation of Clinical Outcomes in Participants With Parkinson’s Disease Through 4 Years After Bemdaneprocel Administration

C. Henchcliffe, H. Sarva, A. Fasano, A. Lozano, S. Kalia, KKH. Yu, C. Brennan, M. Louie-Gao, N. Floro, G. Belfort, V. Tabar (Toronto, Canada)
Continuous Subcutaneous Apomorphine Infusion in Parkinson Disease: Final Data from the Multi-Year InfusON Open-Label Extension Study

P. Lewitt, S. Isaacson, A. Espay, S. Reyes, A. Formella, G. Ceresoli-Borroni (Detroit, USA)
Continuous Subcutaneous Foslevodopa/Foscarbidopa After Deep Brain Stimulation or Levodopa–Carbidopa Intestinal Gel: A Case Series in Advanced Parkinson’s Disease

Y. Abdelmajid, M. Thomas, K. Waqar, E. de Freitas, R. Cabrito, R. Battah, A. Anjum, S. Om Mittal (Abu Dhabi, United Arab Emirates)
Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in Advanced Parkinson’s Disease: Results from a Prospective Real-world Study

G. Pinola, V. Leta, M. Tosi, C. Leuzzi, F. Colucci, G. Gaudiano, A. Braccia, F. Pirone, S. Rinaldo, R. Cancilla, N. Golfrè Andreasi, L. Romito, G. Devigili, R. Cilia, AE. Elia, R. Eleopra (Milano, Italy)
Continuous subcutaneous levodopa infusion in advanced Parkinson’s disease: a descriptive real-world cohort study

P. Prendes Fernandez, P. Tartiere Gonzalez, E. Suarez Sanmartin, C. Garcia Fernandez, L. Gonzalez Alvarez, M. Blazquez Estrada (Oviedo, Spain)
Continuous Subcutaneous Levodopa Therapy Improves Motor Fluctuations and Quality of Life in Parkinson’s Disease: Evidence from Meta-analysis of Clinical Trials

K. Sarhan (Mansoura, Egypt)
Contribution of blood lipid profile to long-term outcome in idiopathic normal pressure hydrocephalus

J. Bissacco, D. Mascioli, C. Simonetta, M. Mancini, V. Buttarazzi, M. Conti, F. Veltri, S. Bagetta, M. Pierantozzi, A. Stefani, F. Buttari, D. Centonze, A. Pesce, M. Pieri, S. Borrelli, F. Di Giuliano, T. Schirinzi (Pozzilli, Italy)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z